Selected research
Industry Research
Microarray Services Industry Research Report 2026
Market perspective
The global Microarray Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Microarray Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Microarray Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Microarray Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Microarray Services include Merck, Thermo Fisher Scientific, SCHOTT, Psomagen, PerkinElmer, OGT, Molecular Devices, LC Sciences and Illumina, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Microarray Services market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Microarray Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Microarray Services Market by Company
Merck
Thermo Fisher Scientific
SCHOTT
Psomagen
PerkinElmer
OGT
Molecular Devices
LC Sciences
Illumina
Hokkaido System Science
GE Healthcare
Creative Biolabs
CD Genomics
Bio-Rad Laboratories
Bionexus
Arrayit
Agilent
Affymetrix
Microarray Services Segment by Type
Gene Expression Microarray
Genotyping Microarray
Methylation Microarray
Transcriptome Microarray
Microarray Services Segment by Application
Drug Development
Medical Research
Others
Microarray Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microarray Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microarray Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microarray Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Microarray Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gene Expression Microarray
- Genotyping Microarray
- Methylation Microarray
- Transcriptome Microarray
Applications
- Drug Development
- Medical Research
- Others
Companies covered
- Merck
- Thermo Fisher Scientific
- SCHOTT
- Psomagen
- PerkinElmer
- OGT
- Molecular Devices
- LC Sciences
- Illumina
- Hokkaido System Science
- GE Healthcare
- Creative Biolabs
- CD Genomics
- Bio-Rad Laboratories
- Bionexus
- Arrayit
- Agilent
- Affymetrix
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Microarray Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Gene Expression Microarray
- 2.2.3 Genotyping Microarray
- 2.2.4 Methylation Microarray
- 2.2.5 Transcriptome Microarray
- 2.3 Microarray Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug Development
- 2.3.3 Medical Research
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Microarray Services Breakdown Data by Type
- 3.1 Global Microarray Services Historic Market Size by Type (2021-2026)
- 3.2 Global Microarray Services Forecasted Market Size by Type (2027-2032)
4 Microarray Services Breakdown Data by Application
- 4.1 Global Microarray Services Historic Market Size by Application (2021-2026)
- 4.2 Global Microarray Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Microarray Services Market Perspective (2021-2032)
- 5.2 Global Microarray Services Growth Trends by Region
- 5.2.1 Global Microarray Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Microarray Services Historic Market Size by Region (2021-2026)
- 5.2.3 Microarray Services Forecasted Market Size by Region (2027-2032)
- 5.3 Microarray Services Market Dynamics
- 5.3.1 Microarray Services Industry Trends
- 5.3.2 Microarray Services Market Drivers
- 5.3.3 Microarray Services Market Challenges
- 5.3.4 Microarray Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Microarray Services Players by Revenue
- 6.1.1 Global Top Microarray Services Players by Revenue (2021-2026)
- 6.1.2 Global Microarray Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Microarray Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Microarray Services Head Office and Area Served
- 6.4 Global Microarray Services Players, Product Type & Application
- 6.5 Global Microarray Services Manufacturers Established Date
- 6.6 Global Microarray Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Microarray Services Market Size (2021-2032)
- 7.2 North America Microarray Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Microarray Services Market Size by Country (2021-2026)
- 7.4 North America Microarray Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Microarray Services Market Size (2021-2032)
- 8.2 Europe Microarray Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Microarray Services Market Size by Country (2021-2026)
- 8.4 Europe Microarray Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Microarray Services Market Size (2021-2032)
- 9.2 Asia-Pacific Microarray Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Microarray Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Microarray Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Microarray Services Market Size (2021-2032)
- 10.2 South America Microarray Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Microarray Services Market Size by Country (2021-2026)
- 10.4 South America Microarray Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Microarray Services Market Size (2021-2032)
- 11.2 Middle East & Africa Microarray Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Microarray Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Microarray Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Merck
- 12.1.1 Merck Company Information
- 12.1.2 Merck Business Overview
- 12.1.3 Merck Revenue in Microarray Services Business (2021-2026)
- 12.1.4 Merck Microarray Services Product Portfolio
- 12.1.5 Merck Recent Developments
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Company Information
- 12.2.2 Thermo Fisher Scientific Business Overview
- 12.2.3 Thermo Fisher Scientific Revenue in Microarray Services Business (2021-2026)
- 12.2.4 Thermo Fisher Scientific Microarray Services Product Portfolio
- 12.2.5 Thermo Fisher Scientific Recent Developments
- 12.3 SCHOTT
- 12.3.1 SCHOTT Company Information
- 12.3.2 SCHOTT Business Overview
- 12.3.3 SCHOTT Revenue in Microarray Services Business (2021-2026)
- 12.3.4 SCHOTT Microarray Services Product Portfolio
- 12.3.5 SCHOTT Recent Developments
- 12.4 Psomagen
- 12.4.1 Psomagen Company Information
- 12.4.2 Psomagen Business Overview
- 12.4.3 Psomagen Revenue in Microarray Services Business (2021-2026)
- 12.4.4 Psomagen Microarray Services Product Portfolio
- 12.4.5 Psomagen Recent Developments
- 12.5 PerkinElmer
- 12.5.1 PerkinElmer Company Information
- 12.5.2 PerkinElmer Business Overview
- 12.5.3 PerkinElmer Revenue in Microarray Services Business (2021-2026)
- 12.5.4 PerkinElmer Microarray Services Product Portfolio
- 12.5.5 PerkinElmer Recent Developments
- 12.6 OGT
- 12.6.1 OGT Company Information
- 12.6.2 OGT Business Overview
- 12.6.3 OGT Revenue in Microarray Services Business (2021-2026)
- 12.6.4 OGT Microarray Services Product Portfolio
- 12.6.5 OGT Recent Developments
- 12.7 Molecular Devices
- 12.7.1 Molecular Devices Company Information
- 12.7.2 Molecular Devices Business Overview
- 12.7.3 Molecular Devices Revenue in Microarray Services Business (2021-2026)
- 12.7.4 Molecular Devices Microarray Services Product Portfolio
- 12.7.5 Molecular Devices Recent Developments
- 12.8 LC Sciences
- 12.8.1 LC Sciences Company Information
- 12.8.2 LC Sciences Business Overview
- 12.8.3 LC Sciences Revenue in Microarray Services Business (2021-2026)
- 12.8.4 LC Sciences Microarray Services Product Portfolio
- 12.8.5 LC Sciences Recent Developments
- 12.9 Illumina
- 12.9.1 Illumina Company Information
- 12.9.2 Illumina Business Overview
- 12.9.3 Illumina Revenue in Microarray Services Business (2021-2026)
- 12.9.4 Illumina Microarray Services Product Portfolio
- 12.9.5 Illumina Recent Developments
- 12.10 Hokkaido System Science
- 12.10.1 Hokkaido System Science Company Information
- 12.10.2 Hokkaido System Science Business Overview
- 12.10.3 Hokkaido System Science Revenue in Microarray Services Business (2021-2026)
- 12.10.4 Hokkaido System Science Microarray Services Product Portfolio
- 12.10.5 Hokkaido System Science Recent Developments
- 12.11 GE Healthcare
- 12.11.1 GE Healthcare Company Information
- 12.11.2 GE Healthcare Business Overview
- 12.11.3 GE Healthcare Revenue in Microarray Services Business (2021-2026)
- 12.11.4 GE Healthcare Microarray Services Product Portfolio
- 12.11.5 GE Healthcare Recent Developments
- 12.12 Creative Biolabs
- 12.12.1 Creative Biolabs Company Information
- 12.12.2 Creative Biolabs Business Overview
- 12.12.3 Creative Biolabs Revenue in Microarray Services Business (2021-2026)
- 12.12.4 Creative Biolabs Microarray Services Product Portfolio
- 12.12.5 Creative Biolabs Recent Developments
- 12.13 CD Genomics
- 12.13.1 CD Genomics Company Information
- 12.13.2 CD Genomics Business Overview
- 12.13.3 CD Genomics Revenue in Microarray Services Business (2021-2026)
- 12.13.4 CD Genomics Microarray Services Product Portfolio
- 12.13.5 CD Genomics Recent Developments
- 12.14 Bio-Rad Laboratories
- 12.14.1 Bio-Rad Laboratories Company Information
- 12.14.2 Bio-Rad Laboratories Business Overview
- 12.14.3 Bio-Rad Laboratories Revenue in Microarray Services Business (2021-2026)
- 12.14.4 Bio-Rad Laboratories Microarray Services Product Portfolio
- 12.14.5 Bio-Rad Laboratories Recent Developments
- 12.15 Bionexus
- 12.15.1 Bionexus Company Information
- 12.15.2 Bionexus Business Overview
- 12.15.3 Bionexus Revenue in Microarray Services Business (2021-2026)
- 12.15.4 Bionexus Microarray Services Product Portfolio
- 12.15.5 Bionexus Recent Developments
- 12.16 Arrayit
- 12.16.1 Arrayit Company Information
- 12.16.2 Arrayit Business Overview
- 12.16.3 Arrayit Revenue in Microarray Services Business (2021-2026)
- 12.16.4 Arrayit Microarray Services Product Portfolio
- 12.16.5 Arrayit Recent Developments
- 12.17 Agilent
- 12.17.1 Agilent Company Information
- 12.17.2 Agilent Business Overview
- 12.17.3 Agilent Revenue in Microarray Services Business (2021-2026)
- 12.17.4 Agilent Microarray Services Product Portfolio
- 12.17.5 Agilent Recent Developments
- 12.18 Affymetrix
- 12.18.1 Affymetrix Company Information
- 12.18.2 Affymetrix Business Overview
- 12.18.3 Affymetrix Revenue in Microarray Services Business (2021-2026)
- 12.18.4 Affymetrix Microarray Services Product Portfolio
- 12.18.5 Affymetrix Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst